Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction
Condition(s) studied
Investigational drug(s) / intervention(s)
Remote dielectric sensing system: The remote dielectric sensing (ReDS) system is a non-invasive medical device that emits a low-power electromagnetic signal through the chest and lungs, which can accurately measure changes in lung fluid concentration.
Study summary
To explore whether a ReDS-guided strategy for AMI patients with cardiac insufficiency following coronary flow reperfusion is superior to routine care for improving outcomes.
Eligibility
Primary outcome measure(s)
- Major adverse cardiac event (MACE) — 1 year
The primary outcome is the MACE that is defined as a composite of all-cause death and HF readmission.
Trial sites (6)
| Facility | City | Region | Status |
|---|---|---|---|
| Huaihe Hospital of Henan University | Kaifeng | Henan | |
| Kaifeng Central Hospital | Kaifeng | Henan | |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | Henan | |
| Shanghai Tenth People's Hospital | Shanghai | Shanghai Municipality | |
| Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine Shanghai | Shanghai | Shanghai Municipality | |
| Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai | Shanghai Municipality |
More Shanghai 10th People's Hospital trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06671067 on ClinicalTrials.gov ↗ ← All trials in China